Recent research highlights the potential of targeting the brain’s metabolism to treat Alzheimer’s disease, a condition that ...

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...

Dr Fares Qeadan, the paper’s primary author, explains to Popular Science that opioids and alcohol were chosen for the study because “both … interact with reward pathways in the brain that GLP-1 ...

A study that used a specialized type of magnetic resonance imaging (MRI)--neuromelanin-sensitive MRI-- has shown that this ...

Antidepressants, the gold standard treatment for depression, don’t work for many people. Will psilocybin be an alternative?

Brain Network Study Reveals Clues About Dementia's Behavior Changes Oct. 7 ... Promising 'First' in Alzheimer's Drug Development Oct. 3, 2024 — An international team of researchers have made ...

Brain Network Study Reveals Clues About Dementia's Behavior Changes Oct. 7 ... made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time ...

However, the modulation of neuronal signals is critical not only for treating circuit disorders but also for identifying ...

“While we hypothesized that these medications might impact cravings and reward-seeking behavior ... brain and similar to their actions on food, they also curb their craving for addictive drugs ...

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...

New research reveals that different fears activate unique brain regions, challenging the idea of a universal fear circuit.

Patients with PMDD have lower levels of cortisol and beta-endorphins during both the follicular and luteal phases, suggesting ...